|Chairman :||Mr. Tse Ping|
|Vice Chairwoman :||Miss Tse, Theresa|
Mr. Tse Ping is the Founder and Chairman of the Company. He is responsible for the overall operations of the Group. With more than 21 years of pharmaceutical related investment and management experience, he is currently a director of JCTT, NJCTT, Jiangsu Fenghai, Yancheng Suhai, Qingdao Haier, Qingdao Chia Tai Haier Medicines Co., Ltd., Qingdao Heng Seng Tang Pharmacy Co., Ltd., Beijing Tide and CT Green Continent. He is also a non-executive director of Tianjin Binhai Teda Logistics (Group) Corporation Limited, the shares of which are listed on GEM Board of The Stock Exchange of Hong Kong Limited. Mr. Tse was formerly the vice chairman of C.P. Lotus Corporation, the shares of which are listed on the main board of the Stock Exchange. Mr. Tse was also formerly the vice chairman of Shenzhen 999 Pharmaceutical Co., Ltd., and was involved in the management of Hainan Haiyao Co., Ltd. (formerly known as Hainan Pharmaceutical Industrial Joint-Stock Company Limited), which is now listed on the Shenzhen Stock Exchange in the PRC. Mr. Tse was also formerly the chairman of Chia Tai Qingchunbao Pharmaceutical Co., Ltd. (“CTQ”) which is now a subsidiary of Shanghai Industrial Investment (Holdings) Co., Ltd., the chairman of Xian CP and the executive chairman of TM International Bank Co., Ltd, based in Shanghai. Mr. Tse is still a director of CTQ, a committee member of the Association of Pharmaceutical Biotechnology of China and an honoral professor of Shenyang University of Pharmacy.
Within the contemporary pharmaceutical industry, with the leadership by Mr. Tse Ping, Sino Biopharmaceutical Limited’s market in hepatitis medicines and the therapeutic segment of micro-sphere target sustained medicine demonstrate a leading position. JCTT and Beijing Tide were ranked the top 100 profit-making enterprises under the National Pharmaceutical Industrial Statistics Annual Report. In November, 2005, the Company was awarded “Best under 1 US Billion enterprise within the Asian Pacific Region” by Forbes Asia. At the first “Capital – Chinese Outstanding Enterprise Achievement Prize” campaign launched by the Capital Magazine, the Company was awarded “Capital – Chinese Outstanding Pharmaceutical Group Prize” in May, 2006. In January, 2008, Mr. Tse was awarded in Hong Kong with “the World Outstanding Chinese” and a honorable Doctor Degree by the University of West Alabama, United States of America. In December, 2008, he was awarded “2007/2008 Asian Knowledge Management Association academician” by the Asian Knowledge Management Association. In June, 2010, Mr. Tse was awarded “The Top Ten Most Leading Innovative Persons of the PRC Enterprises in 2010” by the PRC Productivity Society and the PRC Corporation Press.
Mr. Tse was a member of the Ninth, Tenth and Eleventh National Committee of the Chinese People’s Political Consultative Conference. He is currently the vice chairman of Association of Chinese Natives Chamber of Commerce in the PRC. Mr. Tse is also the vice chairman of Association of Chinese Multinational Corporation.
Miss Tse, Theresa, aged 23, was appointed as Vice Chairwoman of CP Pharmaceutical Group, Chairwoman of Sino Biopharmceutical Limited (a listed company in Hong Kong, stock code 1177). She holds a Bachelor Degree of Science in Economics from the Wharton School of University of Pennsylvania. Throughout her coursework, she focused on the study of Finance and Healthcare. Previously, she worked in the investment, finance and business development departments of several companies.